Literature DB >> 67373

Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

R N Buick, J E Till, E A McCulloch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 67373     DOI： 10.1016/s0140-6736(77)92818-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine.

Authors:  I W Blau; E Elstner; M Waechter; R Ihle; M von Janta-Lipinski; P Langen
Journal:  Blut       Date:  1989-11

2.  1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.

Authors:  S Peleg; H Qiu; S Reddy; D Harris; Q Van; E H Estey; M Talpaz; Z Estrov
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.

Authors:  Geoffrey A Bartholomeusz; Moshe Talpaz; Vaibhav Kapuria; Ling Yuan Kong; Shimei Wang; Zeev Estrov; Waldemar Priebe; Ji Wu; Nicholas J Donato
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 4.  Biology and relevance of human acute myeloid leukemia stem cells.

Authors:  Daniel Thomas; Ravindra Majeti
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

5.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.

Authors:  S Dutta; A Krause; S Vosberg; T Herold; B Ksienzyk; L Quintanilla-Martinez; B Tizazu; M Chopra; A Graf; S Krebs; H Blum; P A Greif; A Vetter; K Metzeler; M Rothenberg-Thurley; M R Schneider; M Dahlhoff; K Spiekermann; U Zimber-Strobl; E Wolf; S K Bohlander
Journal:  Leukemia       Date:  2015-12-21       Impact factor: 11.528

7.  Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

Authors:  Bing Z Carter; Marcela Gronda; Zhiliang Wang; Kate Welsh; Clemencia Pinilla; Michael Andreeff; Wendy D Schober; Adel Nefzi; Gregory R Pond; Imtiaz A Mawji; Richard A Houghten; John Ostresh; Joseph Brandwein; Mark D Minden; Andre C Schuh; Richard A Wells; Hans Messner; Kathy Chun; John C Reed; Aaron D Schimmer
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

8.  The effect of refrigeration of bone marrow and peripheral blood on cytogenetic analysis.

Authors:  P K Martin; J D Rowley
Journal:  In Vitro Cell Dev Biol       Date:  1986-07

9.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 10.  Differentiation in human myeloblastic leukemia studied in cell culture.

Authors:  E A McCulloch; R N Buick; S Lan; J E Till
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.